Biotech grants in Belgium

Closed

Funds Brussels companies developing their first technologically innovative prototype or service, covering 50 to 70 percent of the budget for technical and economic validation.

Closed

Funds Brussels companies doing industrial research, experimental development, or process innovation through grants covering 15 to 70 percent of project costs.

Discontinued

Invests in Walloon industrial, healthcare, and technology companies with minority equity for scale and strategic development.

Open

Funds small and medium enterprises across Europe via Eurostars Call 11 for collaborative innovation with international partners.

Open

Funds PIANOFORTE’s 2026-27 continuation, an EU radiation-safety research partnership — only for its current members and any partner who joins them.

Open

Funds a €15M project that turns microbiome signals into a test for spotting cancer risk years ahead of any symptoms.

Open

Funds a €5M programme that pairs EU and Associated Country research institutions with Ukrainian cancer centres for joint training and staff exchanges.

Open

Funds up to four €8-9M grants for teams building AI-driven digital models of a patient's cancer to predict how it develops and guide personalised treatment.

Open

Funds three pragmatic clinical trials, €7-8M each, testing existing cancer immunotherapies in real-world care for patients whose disease resists treatment.

Open

Funds rare-disease research calls, clinical trial networks and shared data for ERDERA's second phase — open only to the existing coordinator.

Open

Supports European deep-tech ventures advancing laboratory research toward validated prototypes and near-market technologies.

Open

Funds a consortium of universities to build a new EIT Label-certified biotech learning pathway for graduates and professionals across Europe.

Open

Funds one consortium to build a certified micro-credentials programme teaching entrepreneurship and innovation to health and life-science students.

Open

Funds existing ERC grant holders in testing the commercial or societal potential of already-funded research through a fixed EUR 150,000 top-up grant.

Open

Funds €9M research consortia that map, monitor and identify deep-sea species and habitats to guide EU and global ocean protection targets.

Open

Funds €5M lump-sum projects that build sensor and lab-based methods to map, test and protect Europe's groundwater ecosystems.

Open

Funds two €4M projects for European consortia building bio-based products and studying whether people will actually adopt them.

Open

Funds research consortia developing the pre-normative science behind future standards for bio-based chemicals, polymers and other bio-based products.

Open

Funds three €4M lump-sum grants for industrial and environmental biotech — synthetic biology, gene editing, biofoundries — not health biotech or biofuels.

Open

Funds two €5M projects turning marine organisms — algae, fungi, invertebrates — into safer bio-based replacements for adhesives, coatings and chemicals.

Open

Funds consortia developing biotech and nature-based decontamination methods for war-damaged land, water and air, proven on real sites in Ukraine.

Funds EU bio-based innovation projects with up to Euro20 million per topic.

Open

Funds one €20M innovation project that scales alternative proteins, oils, fibres or specialty carbohydrates into safe, accepted food ingredients.

Open

Funds one €20M project that turns bio-based chemicals and ingredients into safer, sustainable home and personal care products at industrial scale.